Position in JNJ
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$1,131,369,551
+$34,048,818 QoQ
Shares Held
4,454,737
-0.8% QoQ
Ownership
0.185%
of shares outstanding
% of Portfolio
1.28%
of 13F equity value
Holder Rank
#62
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 93%
Shared 0%
None 7%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026STIFEL FINANCIAL CORP holds $5,426,093,696 across 17 Drug Manufacturers - General names. JNJ ranks #1 (20.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
4,454,737 | $1,131,369,551 | |
| 2 | MRK |
Merck & Co., Inc.
|
8,169,394 | $1,049,767,127 | |
| 3 | LLY |
ELI LILLY & Co
|
786,902 | $943,833,942 | |
| 4 | ABBV |
AbbVie Inc.
|
3,625,155 | $912,234,002 | |
| 5 | AMGN |
Amgen Inc
|
1,548,229 | $560,644,681 | |
| 6 | PFE |
Pfizer Inc
|
9,980,325 | $240,326,222 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
1,152,519 | $145,609,245 | |
| 8 | AZN |
Astrazeneca PLC
|
670,847 | $127,206,004 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,131,369,551 | 4,454,737 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $1,097,320,733 | 4,489,121 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $1,014,881,762 | 4,903,995 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $938,912,919 | 5,063,709 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $758,274,675 | 4,964,155 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $830,241,969 | 5,006,283 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $663,978,762 | 4,591,196 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $744,947,358 | 4,596,738 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $649,572,161 | 4,444,254 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $692,961,100 | 4,380,562 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $675,194,538 | 4,307,736 | Shares | Defined | 2024-02-12 | |
| 2023-09-30 | $670,701,239 | 4,306,268 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $692,763,596 | 4,185,377 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $629,968,515 | 4,064,313 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $687,688,377 | 3,892,943 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $618,191,809 | 3,784,230 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $658,480,443 | 3,709,540 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $652,598,075 | 3,682,210 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $608,965,231 | 3,559,743 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $556,843,601 | 3,447,948 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $550,812,634 | 3,343,527 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $534,441,050 | 3,251,847 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $497,070,090 | 3,158,407 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $451,244,111 | 3,030,925 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $411,421,640 | 2,925,561 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $373,278,457 | 2,846,629 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||